Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Rating of “Buy” from Brokerages
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have received an average rating of “Buy” from the five ratings firms that are currently covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have covered the stock in […]
More Stories
1,791 Shares in Tesla, Inc. (NASDAQ:TSLA) Acquired by Manning & Napier Advisors LLC
Manning & Napier Advisors LLC bought a new stake in shares of Tesla, Inc. (NASDAQ:TSLA – Free Report) in the...
Promising Large Cap Stocks To Add to Your Watchlist – June 22nd
Tesla, NVIDIA, Invesco QQQ, Circle Internet Group, and Apple are the five Large Cap stocks to watch today, according to...
Captain James Cook’s Endeavour Found? Not So Fast!
By Dustin Bass The Australian National Maritime Museum (ANMM) issued its “Final Report” on June 3, claiming that it “outlines...
Amazon Accelerates Plans to Expand Same-Day Delivery to Rural America
By Wesley Brown Amazon is accelerating its previous plans to expand its same-day delivery service to more than 4,000 smaller...
As Cease-Fire Holds, Trump Says He Doesn’t Want Regime Change in Iran
By Jack Phillips President Donald Trump said on Tuesday he’s not seeking regime change in Iran. The comments come two...
US Consumer Confidence Falls in June: Conference Board Index
By Naveen Athrappully U.S. consumer confidence fell in June, canceling some of the growth showcased last month, according to a...